Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  epoetin beta
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: AGOSG-OVAR-MO16375-MARCH, CDR0000257189, EU-20217, ROCHE-MO16375, ROCHE-RO2053859, NCT00046969
An Observational Study of Blood Management Techniques in Oncology Surgical Treatment
Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003460, EPOSUR4001, NCT00264095
A Study of the Quality of Life and Treatment Response to Once Weekly NeoRecormon (Epoetin Beta) Treatment in Anemic Patients With Solid and Lymphoid Malignancies.
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML20197, NCT00776425
Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 20 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: EPO316 JP, NCT00628043
Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 61 to 75
Sponsor: Other
Protocol IDs: BACOPP-21, NCT00284271
Epoetin Beta in Treating Fatigue and Anemia in Patients Receiving Palliative Care for Malignant Solid Tumors
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000574173, CHUL-NEOPALIA, RECF0359, NEOPALIA, NCT00559195
A Study of NeoRecormon (Epoetin Beta), CellCept (Mycophenolate Mofetil) and Prednisone in Patients With Low or Intermediate Myelodysplastic Syndromes.
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML20559, NCT00551291
Evaluation of Azacitidine in Transfusion Dependent Patients With Low-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NMDSG08A, 2009-011483-11, NCT01048034
Lenalidomide in Subject With Low and Intermediate-1 Risk MDS and Without Chromosome 5 Abnormality.
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: GFM-Len-Epo-08, NCT01718379
Start Over